Picture of Metlife logo

MET Metlife News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsConservativeLarge CapSuper Stock

MetLife Inc reports results for the quarter ended December 31 - Earnings Summary

* MetLife Inc  MET.N  reported quarterly adjusted earnings
of
$2.08​​ per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of
$1.93.  The mean expectation of fifteen analysts for the quarter
was for earnings of $2.10 per share. Wall Street expected
results to range from $1.96  to $2.25 per share.
    * Revenue rose 5.4% to $19.74 billion from a year ago;
analysts
expected $19.50 billion. 
    * MetLife Inc's reported EPS for the quarter was $1.78​.
    * The company reported quarterly net income of $1.24
billion.
    * MetLife Inc shares had risen by 3.4% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 7.8%
in the last three months.​ 
    * In the last 30 days, eight analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the life & health
insurance peer group is also "buy"

Wall Street's median 12-month price target for MetLife Inc is
$97.00 
This summary was machine generated from LSEG data February 5 at
10:44 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      2.10           2.08           Missed
 Sep. 30 2024      2.17           1.95           Missed
 Jun. 30 2024      2.10           2.28           Beat
 Mar. 31 2024      1.81           1.83           Beat

Recent news on Metlife

See all news